510(k) Report

510(k) · Cleared

Cleared

Revolix 120

K070476510(k) SpecialCleared Mar 26, 200734-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Allmed Systems, Inc. · GEX Powered Laser Surgical Instrument

Cleared on Mar 26, 2007 after a 34-day review. The FDA summary names its predicate without a number. 214 later devices descend from it.

Decided
Mar 26, 2007
Review
34 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
0

214 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2011: 5 descendants cleared2017: 7 descendants cleared2009: 1 descendant cleared2008: 2 descendants cleared2010: 7 descendants cleared2013: 8 descendants cleared2022: 24 descendants cleared2019: 8 descendants cleared2025: 30 descendants cleared2012: 4 descendants cleared2015: 10 descendants cleared2021: 11 descendants cleared2023: 12 descendants cleared2026: 18 descendants cleared2016: 10 descendants cleared2024: 24 descendants cleared2014: 8 descendants cleared2018: 11 descendants cleared2020: 14 descendants cleared20052010201520202025
  1. This deviceK070476 Revolix 120Allmed Systems, Inc. · 2007
  2. Descendant · cites it directly · 194 of its ownK072682 50W Ceralas D 1950NM Diode LaserBiolitec, Inc. · 2008
  3. Descendant · 2 generations on · 192 of its ownK083613 Quanta System Polysurge Diode Laser FamilyQuanta System Spa · 2008
  4. Descendant · 2 generations on · 112 of its ownK082230 Vectra Plus Laser System and AccessoriesXintec Corporation · 2010
  5. Descendant · 3 generations on · 111 of its ownK101916 Joule Multi-Platform SystemSciton, Inc · 2011
  6. Descendant · 4 generations on · 70 of its ownK132806 Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D. · 2014

Showing 5 of 214 descendants. See all descendants

Descendants cleared per year

2008: 22009: 12010: 72011: 52012: 42013: 82014: 82015: 102016: 102017: 72018: 112019: 82020: 142021: 112022: 242023: 122024: 242025: 302026: 18
2008high 30 (2025) · low 1 (2009)2026

Most influential descendants

Showing 5 of 214 · See all
  • K07268250W Ceralas D 1950NM Diode LaserBiolitec, Inc. · 2008 · cites it directly194descendants
  • K083613Quanta System Polysurge Diode Laser FamilyQuanta System Spa · 2008 · 2 generations on192descendants
  • K082230Vectra Plus Laser System and AccessoriesXintec Corporation · 2010 · 2 generations on112descendants
  • K101916Joule Multi-Platform SystemSciton, Inc · 2011 · 3 generations on111descendants
  • K132806Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D. · 2014 · 4 generations on70descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K070476Revolix 120Allmed Systems, Inc.2007—
+1K07268250W Ceralas D 1950NM Diode LaserBiolitec, Inc.2008—
+2K083613Quanta System Polysurge Diode Laser FamilyQuanta System Spa2008—
+2K082230Vectra Plus Laser System and AccessoriesXintec Corporation2010—
+3K101916Joule Multi-Platform SystemSciton, Inc2011—
+4K132806Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200820
200910
201070
201150
201240
201380
201480
2015100
2016100
201770
2018110
201980
2020140
2021110
2022240
2023120
2024240
2025300
2026180
FIG. 1 — Lineage of K070476, 2007–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Lumenis/Coherent Medical - VersaPulse Ho:YAG 100 watt
Named without a submission number
—
*—Trimedyne Omnipulse Max 50 watt
Named without a submission number
—
*—RevoLix 90 waftt
Named without a submission number
—

What descends from it? (214)

See all 214

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K07268250W Ceralas D 1950NM Diode LaserBiolitec, Inc.2008194
K103654Vela XLStarmedtec GmbH201114
K090962Cyber Surgical Laser Family Including: Cyber TM, Cyber Green, Cyber Green TMQuanta System Spa20098
K162334U.S. Laser Worx Patriot 1 family of lasersU.S. Laser Worx20171

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K072682 (Biolitec, Inc., 2008) has gone furthest, with 194 descendants of its own.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Revolix 120 laser systems and its fiber optic delivery system are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including: Urology, Gastroenterology, Thoracic and Pulmonary, Gynecology, ENT, Dermatology, Plastic Surgery, General Surgery.and Arthroscopy Urology Open and endoscopic surgery…

Read the full statement (459 words)

The Revolix 120 laser systems and its fiber optic delivery system are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft tissue in use in medical specialties including: Urology, Gastroenterology, Thoracic and Pulmonary, Gynecology, ENT, Dermatology, Plastic Surgery, General Surgery.and Arthroscopy

Urology

Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:

Urethral Strictures

Bladder Neck Incisions (BNI)

Ablation and resection of Bladder Tumors, Uretheral Tumors and Ureteral Tumors.

Ablation of Benign Prostatic Hypertrophy (BHP),

Transurethral incision of the prostate (TUIP)

Laser Resection of the Prostrate (HoLRP)

Laser Enuculeation of the Prostate (HoLEP)

Laser Ablation of the Prostate (HoLAP)

Condylomas

Lesions of external genitalia

Gastroenteroloqy

Open and endoscopic gastroenterology surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis ) including:

Appendectomy

Polyps

Biopsy

Gall Bladder calculi

Biliary/Bile duct calculi

Ulcers

Gastric ulcers

Duodenal ulcers

Non Bleeding Ulcers

Pancreatitas

Hemorrhoids

Cholecystectomy

Benign and Malignant Neoplasm

Angiodysplasia

Colorectal cancer

Telangiectasias

Telangiectasias of the Osler-Weber-Renu disease

Vascular Malformation

Gastritis

Esophagitis

Esophageal ulcers

Varices

Colitis

Mallory-Weiss tear

Gastric Erosions

Thoracic and Pulmonary

Open and endoscopic thoracic and pulmonary surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue

Laryngeal Lesions

Airway obstructions including carcinoma

Polyps and Granulomas

Palliation of obstructing carcinomas of the tracheobronchial tree

Gynecology

Open and laparoscopic gynecological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis)

Intra-uterine treatment of submucous fibroids, benign endometrial polyps, and uterine septum by incision, excision, ablation and or vessel coagulation

Soft tissue excision procedures such as excisional conization of the cervix

ENT

Endoscopic endonasal surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft tissue) including:

Endonasal/sinus Surgery

Partial turbinectomy

Polypectomy

Dacryocystorhinostomy

Frontal Sinusotomy

Ethmoidectomy

Maxillary antrostomy

Functional endoscopic sinus surgery

Lesions or tumors of the oral, nasal, glossal, pharyngeal and laryngeal

Tonsillectomy

Adenoidectomy

Dermatology and Plastic Surgery

Incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft, mucosal, fatty and cartilaginous tissue, in therapeutic plastic, dermatologic and aesthetic surgical procedures including:

Basal Cell Carcinomas

Lesions of skin and subcutaneous tissue

Skin tags

Plantar warts

General Surqery

Open laparoscopic and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:

Cholecystectomy

Lysis of adhesion

Appendectomy

Biopsy

Skin incision

Tissue dissection

Excision of external tumors and lesions

Complete or partial resection of internal organs, tumors and lesions

Mastectomy

Hepatectomy

Pancreatectomy

Splenectomy

Thyroidectomy

Parathyroidectomy

Herniorrhaphy

Tonsillectomy

Lymphadenectomy

Partial Nephrectomy

Pilonidal Cystectomy

Resection of lipoma

Debridement of Decubitus Ulcer

Hemorrhoids

Debridement of Statis Ulcer

Biopsy

Arthroscopy

Arthroscopy/Orthopedic surgery (excision, ablation and coagulation of soft and cartilaginous tissue)

Ablation of soft and cartilaginous tissue in Minimal Invasive Spinal Surgery including

Percutaneous Laser Disc Decompression/Discectomy

Foraminoplasty

Ablation and coagulation of soft vascular and non vascular tissue in minimally invasive spinal surgery.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K070476: Revolix 120.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070476

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026